Antibodies to retrovirus proteins in scleroderma

Area of Science:

• Immunology
• Virology
• Rheumatology

Background:

• Scleroderma is a complex autoimmune disease with unknown etiology.
• The potential role of viral infections, including retroviruses, in autoimmune pathogenesis is an area of ongoing research.

Purpose of the Study:

• To investigate the presence of antibodies to human immunodeficiency virus (HIV) proteins in patients with scleroderma.
• To explore potential correlations between these antibodies and clinical manifestations or other autoantibodies.

Main Methods:

• Western blot analysis was performed on sera from 29 scleroderma patients.
• Reactivity was assessed against specific HIV retroviral proteins (p18, p24, p55, p65).
• Cross-reactivity testing included cytomegalovirus (CMV), human T-cell lymphotropic virus type I (HTLV-I), Epstein-Barr virus (EBV), and scleroderma-associated autoantibodies like anti-topoisomerase (Scl 70).

Main Results:

• Antibodies to one or two HIV proteins were found in 8 out of 29 scleroderma patients, typically with weak reactivity.
• No clear clinical correlations were identified with specific antibody bands.
• No evidence of direct HIV infection was found in the patient cohort.
• Limited cross-reactivity was observed with CMV (3 cases), but not with HTLV-I, EBV, or common scleroderma autoantibodies.

Conclusions:

• The study identified antibodies to HIV proteins in a subset of scleroderma patients.
• The findings do not indicate direct HIV infection and suggest potential molecular mimicry as a possible explanation.
• Further research is needed to elucidate the role of retroviruses in scleroderma pathogenesis.